Cargando...
The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
PURPOSE OF REVIEW: Biologics are well established in the treatment of many immuno-inflammatory diseases including inflammatory bowel disease (IBD). However, although primary sclerosing cholangitis (PSC) is closely associated with IBD, the role of biologics in PSC remains uncertain. Many new biologic...
Gardado en:
| Publicado en: | Curr Hepatol Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6445403/ https://ncbi.nlm.nih.gov/pubmed/31008013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11901-019-00456-2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|